Your browser doesn't support javascript.
loading
Occurrence of symptoms in different stages of Duchenne muscular dystrophy and their impact on social participation.
Houwen-van Opstal, Saskia L S; Heutinck, Lotte; Jansen, Merel; Krom, Yvonne D; Cup, Edith H C; Hendriksen, Jos G M; Willemsen, Michel A A P; Verschuuren, Jan J G M; Niks, Erik H; de Groot, Imelda J M.
Afiliação
  • Houwen-van Opstal SLS; Amalia Children's Hospital, Nijmegen, The Netherlands.
  • Heutinck L; Radboud University, Nijmegen, The Netherlands.
  • Jansen M; Donders Centre for Neuroscience, Nijmegen, The Netherlands.
  • Krom YD; Duchenne Centre Netherlands, Nijmegen and Leiden, The Netherlands.
  • Cup EHC; Radboud University, Nijmegen, The Netherlands.
  • Hendriksen JGM; Duchenne Centre Netherlands, Nijmegen and Leiden, The Netherlands.
  • Willemsen MAAP; Radboud University, Nijmegen, The Netherlands.
  • Verschuuren JJGM; Duchenne Centre Netherlands, Nijmegen and Leiden, The Netherlands.
  • Niks EH; Leiden University Medical Center, Leiden, The Netherlands.
  • de Groot IJM; Radboud University, Nijmegen, The Netherlands.
Muscle Nerve ; 64(6): 701-709, 2021 12.
Article em En | MEDLINE | ID: mdl-34453345
ABSTRACT
INTRODUCTION/

AIMS:

As life expectancy improves for patients with Duchenne muscular dystrophy (DMD), new symptoms are likely to arise. This aims of this study are (1) to explore the prevalence of a broad variety of symptoms in the various stages of DMD (with and without steroid use); (2) to explore the prevalence of common secondary diagnoses; and (3) to evaluate the social participation level of patients with DMD older than 16 y of age; and to explore correlations between social participation and symptoms.

METHODS:

A cross-sectional self-report questionnaire, including questions on functional level and health status, as well as a standardized participation scale was distributed among Dutch patients with DMD.

RESULTS:

Eighty-four male patients with a mean age of 22.0 (SD = 10.0) y were enrolled. The most prevalent and limiting symptoms were difficulty coughing (58%), coldness of hands (57%), contractures (51%), stiffness (49%), fatigue (40%), myalgia (38%), and low speech volume (33%). Prevalent secondary diagnoses included cardiac disease (14%), neurobehavioral diagnosis (13%), low blood pressure (13%), and arthrosis (5%). Social participation correlated negatively with coldness of hands (r = - .29; P < .03), decreased intelligibility (r = - .40; P < .003), and chewing problems (r = - .33; P < .02).

DISCUSSION:

The prevalence of a broad spectrum of symptoms and secondary diagnoses is high in patients with DMD, and some of these symptoms are correlated with social participation. Growing awareness of new symptoms and secondary diagnoses among patients, caregivers, and professionals can enhance their recognition, possibly facilitating prevention and early treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distrofia Muscular de Duchenne / Participação Social Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distrofia Muscular de Duchenne / Participação Social Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article